NEWC is pleased to provide an update of their new joint venture to apply for an orphan drug designation with the FDA for a cannabis based pharmaceutical product within the next few weeks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.